1,468 results on '"Fogelman I"'
Search Results
52. Does Quantitative Ultrasound Imaging Enhance Precision and Discrimination?
53. Cyclical Etidronate Therapy for Prevention of Postmenopausal Bone Loss: A 1-Year Open-Label Follow-Up Study
54. Can the WHO Criteria for Diagnosing Osteoporosis be Applied to Calcaneal Quantitative Ultrasound?
55. Intermittent Oral Disodium Pamidronate in Established Osteoporosis: A 2 Year Double-Masked Placebo-Controlled Study of Efficacy and Safety
56. Long-Term Precision of DXA Scanning Assessed over Seven Years in Forty Postmenopausal Women
57. Risedronate Reduces the Risk of First Vertebral Fracture in Osteoporotic Women
58. Contact Quantitative Ultrasound: An Evaluation of Precision, Fracture Discrimination, Age-Related Bone Loss and Applicability of the WHO Criteria
59. Morphometric X-ray Absorptiometry and Morphometric Radiography of the Spine: A Comparison of Analysis Precision in Normal and Osteoporotic Subjects
60. An Unexpected Change in DXA Calibration not Detected by Routine Quality Control Checks
61. The Effect of Season and Vitamin D Supplementation on Bone Mineral Density in Healthy Women: A Double-Masked Crossover Study
62. F-18-NaF PET/CT: EANM procedure guidelines for bone imaging (vol 2, pg 1767, 2015)
63. Optimizing data acquisition and analysis of morphometric X-ray absorptiometry
64. Vitamin D and bone mineral density
65. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene
66. The Effect of Weight Change on DXA Scans in a 2-Year Trial of Etidronate Therapy
67. Screening for Osteopenia and Osteoporosis: Do the Accepted Normal Ranges Lead to Overdiagnosis?
68. The relationship between gonadotrophins, gonadal hormones and bone mass in men
69. A longitudinal study of supine lateral DXA of the lumbar spine: A comparison with posteroanterior spine, hip and total-body DXA
70. The accuracy of volumetric bone density measurements in dual X-ray absorptiometry
71. Effect of tibolone on postmenopausal bone loss
72. Clinical experience with etidronate in osteoporosis
73. Distribution of bone mineral density in the lumbar spine in health and osteoporosis
74. Fractal signature analysis of macroradiographs measures trabecular organization in lumbar vertebrae of postmenopausal women
75. Patient dose in dual x-ray absorptiometry
76. Measurements of postmenopausal bone loss with a new contact ultrasound system
77. Bone single-photon emission tomography in recent meniscal tears: an assessment of diagnostic criteria
78. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis
79. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease
80. Ultrasonic velocity measurements through the calcaneus: Which velocity should be measured?
81. Measurements of broadband ultrasonic attenuation in the calcaneus in premenopausal and postmenopausal women
82. Comparison of myocardial gated single photon emission computerised tomography, planar radionuclide ventriculography and echocardiography in evaluating left ventricular ejection fraction, wall thickening and wall motion
83. Bisphosphonates and vertebral fracture: An epidemiological perspective
84. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding
85. Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study
86. Survival data from the ZEBRA study
87. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?
88. Quantitative studies of bone using 18F-fluoride and 99mTc-methylene diphosphonate: evaluation of renal and whole-blood kinetics
89. Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer
90. A new tracer test of skeletal function
91. Detecting Bone Size Quantitative Trait Loci Using DXA Imaging
92. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update
93. Management of male osteoporosis: report of the UK Consensus Group
94. Recent advances in bone densitometry
95. 31. Physiological variants in 18FDG PET scanning: Potential for error in interpretation
96. 86. Is lateral DXA superior to posteroanterior scanning for monitoring the response of patients treated for osteoporosis?
97. 87. Radiographer dose in dual-energy X-ray absorptiometry: A comparison with gamma camera and PET scanning
98. A comparison of MRI and bone SPET in the diagnosis of knee pathology
99. SPET bone scanning can predict successful facet joint injection
100. Anterior cruciate ligament tear: Findings on SPET bone scintigraphy of the knee
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.